Toripalimab in Combination With Lenvatinib as Neoadjuvant Therapy in Resectable Hepatocellular Carcinoma
Clinical trial NCT03867370 · TERMINATED
Trial details
- NCT number
- NCT03867370
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-26
- Primary completion
- 2023-08-08
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.